Clinical Trial Update: Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating Cross-Linked Polyelectrolyte (CLP) versus placebo in patients with heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Cross-Linked Polyelectrolyte (CLP)

Snippet

Sponsor: Sorbent Therapeutics | Conditions: Heart Failure | Phase 2 | Status: UNKNOWN